120 related articles for article (PubMed ID: 37806253)
1. BIRC5: A novel therapeutic target for lung cancer stem cells and glioma stem cells.
Kahm YJ; Kim RK
Biochem Biophys Res Commun; 2023 Nov; 682():141-147. PubMed ID: 37806253
[TBL] [Abstract][Full Text] [Related]
2. Impact of KIF4A on Cancer Stem Cells and EMT in Lung Cancer and Glioma.
Kahm YJ; Kim IG; Jung U; Lee JH; Kim RK
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067227
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of Baculoviral Inhibitor of Apoptosis Repeat-Containing 5 (BIRC5) Can Be Associated with Clinical Outcome of Non-Small Cell Lung Cancer.
Szczyrek M; Mlak R; Szudy-Szczyrek A; Wojas-Krawczyk K; Kędziora K; Milanowski J
Cells; 2022 Mar; 11(6):. PubMed ID: 35326407
[TBL] [Abstract][Full Text] [Related]
4. BIRC5 Inhibition Is Associated with Pyroptotic Cell Death via Caspase3-GSDME Pathway in Lung Adenocarcinoma Cells.
Zhang Q; Chen X; Hu Y; Zhou T; Du M; Xu R; Chen Y; Tang P; Chen Z; Li J
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834111
[TBL] [Abstract][Full Text] [Related]
5. BIRC5 Expression is Regulated in Uterine Epithelium During the Estrous Cycle.
Cho M; Lee OH; Chang EM; Lee S; Moon S; Lee J; Park H; Park KH; Park C; Hong K; Choi Y
Genes (Basel); 2020 Mar; 11(3):. PubMed ID: 32155884
[TBL] [Abstract][Full Text] [Related]
6. Lentiviral CRISPR/Cas9 nickase vector mediated BIRC5 editing inhibits epithelial to mesenchymal transition in ovarian cancer cells.
Zhao G; Wang Q; Gu Q; Qiang W; Wei JJ; Dong P; Watari H; Li W; Yue J
Oncotarget; 2017 Nov; 8(55):94666-94680. PubMed ID: 29212257
[TBL] [Abstract][Full Text] [Related]
7. Potential Involvement of
Gil-Kulik P; Krzyżanowski A; Dudzińska E; Karwat J; Chomik P; Świstowska M; Kondracka A; Kwaśniewska A; Cioch M; Jojczuk M; Nogalski A; Kocki J
Oxid Med Cell Longev; 2019; 2019():8727925. PubMed ID: 30774747
[TBL] [Abstract][Full Text] [Related]
8. RanBP1: A Potential Therapeutic Target for Cancer Stem Cells in Lung Cancer and Glioma.
Kahm YJ; Kim IG; Kim RK
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047826
[TBL] [Abstract][Full Text] [Related]
9. CircCAMSAP1 promotes non-small cell lung cancer proliferation and inhibits cell apoptosis by sponging miR-1182 and regulating BIRC5.
Wang Y; Li X; Wang H; Zhang G
Bioengineered; 2022 Feb; 13(2):2428-2439. PubMed ID: 35132928
[TBL] [Abstract][Full Text] [Related]
10. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.
Cao Y; Zhu W; Chen W; Wu J; Hou G; Li Y
Dis Markers; 2019; 2019():5451290. PubMed ID: 31093306
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in a miR-335 binding site in BIRC5 alters susceptibility to lung cancer in Chinese Han populations.
Zu Y; Ban J; Xia Z; Wang J; Cai Y; Ping W; Sun W
Biochem Biophys Res Commun; 2013 Jan; 430(2):529-34. PubMed ID: 23232114
[TBL] [Abstract][Full Text] [Related]
13. BIRC5/Survivin is a novel ATG12-ATG5 conjugate interactor and an autophagy-induced DNA damage suppressor in human cancer and mouse embryonic fibroblast cells.
Lin TY; Chan HH; Chen SH; Sarvagalla S; Chen PS; Coumar MS; Cheng SM; Chang YC; Lin CH; Leung E; Cheung CHA
Autophagy; 2020 Jul; 16(7):1296-1313. PubMed ID: 31612776
[TBL] [Abstract][Full Text] [Related]
14. Survivin' Acute Myeloid Leukaemia-A Personalised Target for inv(16) Patients.
Greiner J; Brown E; Bullinger L; Hills RK; Morris V; Döhner H; Mills KI; Guinn BA
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638823
[TBL] [Abstract][Full Text] [Related]
15. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
[TBL] [Abstract][Full Text] [Related]
16. Association between functional variants in BIRC5/survivin gene 3' untranslated region and mRNA expression in lymphoblastoid cell lines.
Pu F; Shao Z; Yang S; Liu J; Lin S; Ma X; Yang H
Oncol Lett; 2015 Oct; 10(4):2319-2322. PubMed ID: 26622842
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic significance of BIRC5 in breast cancer using integrative bioinformatics analysis.
Dai JB; Zhu B; Lin WJ; Gao HY; Dai H; Zheng L; Shi WH; Chen WX
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32043523
[TBL] [Abstract][Full Text] [Related]
18. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway.
Wang B; Li X; Zhao G; Yan H; Dong P; Watari H; Sims M; Li W; Pfeffer LM; Guo Y; Yue J
J Exp Clin Cancer Res; 2018 Sep; 37(1):235. PubMed ID: 30241553
[TBL] [Abstract][Full Text] [Related]
19. LINC00511 Knockdown Suppresses Resistance to Cisplatin in Lung Adenocarcinoma by Interacting with miR-182-3p and BIRC5.
Zhu Z; Shi Y; Gong X; Li J; Zhang M
Mol Biotechnol; 2022 Mar; 64(3):252-262. PubMed ID: 34595724
[TBL] [Abstract][Full Text] [Related]
20. Increased Expression of
Gil-Kulik P; Świstowska M; Kondracka A; Chomik P; Krzyżanowski A; Kwaśniewska A; Rahnama M; Kocki J
Oxid Med Cell Longev; 2020; 2020():9084730. PubMed ID: 32322338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
